Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: IDDF2026-ABS-0537 ×

IDDF2026-ABS-0537

This institution is selected. Its supporting articles are shown below.

IDDF2026-ABS-05371

Articles mentioning IDDF2026-ABS-0537

1 articles · page 1 of 1

IDDF2026-ABS-0537 Mortality among HCC patients between different systemic therapies of sorafenib, lenvatinib and atezolizumab+bevacizumab

gutjnl · abstract · 2026-06-26 · 1 matching annotations

85.7%

IDDF2026-ABS-0537 Lenvatinib Sorafenib Advanced hepatocellular carcinoma Atezolizumab Bevacizumab

…urvival curve in all-cause and HCC-specific mortality).Abstract IDDF2026-ABS-0537 Figure 1…